RECRUITINGOBSERVATIONAL

Needs of ALS Patients With C9orf72 Mutation and Their Caregivers

Investigation Into the Needs of ALS Patients With C9orf72 Mutation and Their Caregivers

About This Trial

Individuals with Amyotrophic Lateral Sclerosis (ALS) carrying the C9orf72 HRE mutation (C9Pos) often exhibit different phenotypic traits compared to other patients (C9Neg), presenting a more aggressive form of the disease, with also a higher frequency of comorbidity with frontotemporal dementia (ALS-FTD) and a greater prevalence of family history of ALS and/or other neurodegenerative diseases. Considering these characteristics (comorbidity with FTD and family history of ALS and/or other neurodegenerative pathologies) as factors that have their importance from an assistance point of view, both C9orf72 patients and their caregivers may have particular needs in several respects, and in this sense this investigation is configured. This survey aims to describe the various aspects related to the care and quality of life of C9orf72 ALS patients and their respective caregivers, with the goal of identifying actionable steps to improve the quality of life for both.

Who May Be Eligible (Plain English)

ALS Patients: Who May Qualify: - Diagnosis of ALS with mutation C9orf72 (C9Pos) - Age 18 years or older - Fluency in Italian language - Ability to understand the nature of the study and to reply to the questions in the online survey - willing to sign a consent form signed Who Should NOT Join This Trial: - Clinically relevant cognitive dysfunction - Incapacity to reply to at least half of the questions of the online survey - Hospital Anxiety and Depression Scale (HADS) ≥ 11 Caregivers: Who May Qualify: - Caregiver of patient with diagnosis of ALS with mutation C9orf72 (C9Pos), who participates in this study - Age 18 years or older - Preserved cognitive functions - willing to sign a consent form signed Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

ALS Patients: Inclusion Criteria: * Diagnosis of ALS with mutation C9orf72 (C9Pos) * Age 18 years or older * Fluency in Italian language * Ability to understand the nature of the study and to reply to the questions in the online survey * Informed consent signed Exclusion Criteria: * Clinically relevant cognitive dysfunction * Incapacity to reply to at least half of the questions of the online survey * Hospital Anxiety and Depression Scale (HADS) ≥ 11 Caregivers: Inclusion Criteria: * Caregiver of patient with diagnosis of ALS with mutation C9orf72 (C9Pos), who participates in this study * Age 18 years or older * Preserved cognitive functions * Informed consent signed

Treatments Being Tested

OTHER

Survey for ALS patients

Survey to describe the various aspects related to the care, needs and quality of life of C9orf72 ALS patients

OTHER

Survey for Caregivers

Survey to describe the various aspects related to the care and time commitment for the assistance given by caregivers to C9orf72 ALS patients

Locations (3)

Istituto Auxologico Italiano IRCCS

Milan, Lombardy, Italy

IRCCS Ospedale San Raffaele

Milan, Italy

IRCCS Fondazione Mondino, Istituto Neurologico Nazionale a Carattere Scientifico

Pavia, Italy